|
|
A CME Dinner Symposium of April 24, 2007 2.0 AMA PRA Category 1 Credits™ This course will primarily examine the question, "Can type 2 diabetes be prevented?" This course will highlight the results of the DREAM Trial (Diabetes REduction Assessment With Ramipril and Rosiglitizone Medication) and the ADOPT Trial (A Diabetes Outcome Progression Trial) as well as other landmark studies. Click here for LA CME program in PDF. Click here to register. Register by April 20, 2007. Registration is limited to 100 people. There is no registration fee for this dinner CME program. If you must cancel for any reason, please call the Office of Continuing Education at 1-888-229-6263. |
Program Agenda 6:00 p.m. Registration 6:15 p.m. Dinner 7:00 p.m. Advances in the Prevention of Type 2 Diabetes: Examining the Impact of Recent Prevention Trials 8:00 p.m. Case Presentations: Board review style Q&A 9:00 p.m. Adjourn This course is designed for diabetes healthcare providers including primary care physicians, endocrinologists, nurse practitioners, physician assistants and other healthcare providers wanting to expand their knowledge of diabetes management. **Attendees will receive the highly acclaimed, clinically-oriented textbook, Diagnosis and Management of Type 2 Diabetes, by Steven Edelman, MD, and Robert Henry, MD. | |
OBJECTIVES: At the conclusion of this program, participants should be able to: Describe the therapeutic interventions, both pharmacologic and non-pharmacologic, that have been proven to prevent the conversion of pre-diabetes to type 2 diabetes and the progression of the diabetic state. Review the most recent data on preventing and altering the progression of type 2 diabetes utilizing antidiabetic agents. Describe the concept of durable glycemic control achieved by beta cell preservation at all stages in the natural history of type 2 diabetes. Understand the secondary failure rates of different oral agents. Recognize the importance of patient education, motivation and enhanced diabetes self-management in achieving long-term control. |
ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through joint sponsorship of the University of California, San Diego School of Medicine, and Taking Control of Your Diabetes. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of California, San Diego School of Medicine designates this educational activities for a maximum of 2.0 AMA PRA Category 1 Credits™. BRN: Nurses may claim credit for activities approved for AMA PRA Category 1 Credit™ in most states, for up to 50% of the nursing requirement for recertification. This course is designated for 2.0 AMA PRA Category 1 Credits™. Certified Diabetes Educators: To satisfy the requirement for renewal of certification by continuing education for the National Certificaiton Board for Diabetes Diabetes Educators (NCBDE), continuing education activities must be diabetes related and approved by a provider on the NCBDE list of Approved Providers. NCBDE does not approve continuing education. The University of California, San Diego is accredited by the ACCME, which is on the NCBDE list of approved providers. |
|
LOCATION: Millennium Biltmore Hotel - Emerald Room The content of this educational activity was determined by rigorous assessment of educational need and includes expert faculty assessment, literature review, medical practice and new medical knowledge. |
||
We would like to offer very special thanks to GlaxoSmithKline. Their financial support has made this conference possible. |
||
|
||
TAKING CONTROL OF YOUR DIABETES (TCOYD) is a not-for-profit 501(c)3 charitable organization dedicated to educating, motivating and empowering people with diabetes and their loved ones to take a more active role in their own health care. Copyright TCOYD 2006-2007. |
||
